As shown in Table 1, immunohistochemical analysis revealed the absence of SPLUNC1 expression in 93.85% of newly diagnosed NPC tissue specimens, weakly positive expression of SPLUNC1 in 6.15%, and no evidence of positive or strongly positive expression. The gene discussed is BPIFA1; the disease is nasopharyngeal carcinoma.